Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 631

1.

Bleeding and New Cancer Diagnosis in Patients with Atherosclerosis.

Eikelboom JW, Connolly SJ, Bosch J, Shestakovska O, Aboyans V, Alings M, Anand SS, Avezum A, Berkowitz SD, Bhatt DL, Cook Bruns N, Felix C, Fox KAA, Hart RG, Maggioni AP, Moayyedi P, O'Donnell M, Rydén L, Verhamme P, Widimsky P, Zhu J, Yusuf S; COMPASS investigators.

Circulation. 2019 Sep 12. doi: 10.1161/CIRCULATIONAHA.119.041949. [Epub ahead of print]

PMID:
31510769
2.

Clinical impact of antithrombotic therapy in transvenous lead extraction complications: a sub-analysis from the ESC-EORP EHRA ELECTRa (European Lead Extraction ConTRolled) Registry.

Di Cori A, Auricchio A, Regoli F, Blomström-Lundqvist C, Butter C, Dagres N, Deharo JC, Maggioni AP, Kutarski A, Kennergren C, Laroche C, Rinaldi CA, Dovellini EV, Golzio PG, Thøgersen AM, Bongiorni MG; ESC-EHRA ELECTRa Investigators.

Europace. 2019 Jul 1;21(7):1096-1105. doi: 10.1093/europace/euz062.

PMID:
31505593
3.

Clinical presentation, aetiology and outcome of infective endocarditis. Results of the ESC-EORP EURO-ENDO (European infective endocarditis) registry: a prospective cohort study.

Habib G, Erba PA, Iung B, Donal E, Cosyns B, Laroche C, Popescu BA, Prendergast B, Tornos P, Sadeghpour A, Oliver L, Vaskelyte JJ, Sow R, Axler O, Maggioni AP, Lancellotti P.

Eur Heart J. 2019 Sep 3. pii: ehz620. doi: 10.1093/eurheartj/ehz620. [Epub ahead of print]

PMID:
31504413
4.

Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction.

Solomon SD, McMurray JJV, Anand IS, Ge J, Lam CSP, Maggioni AP, Martinez F, Packer M, Pfeffer MA, Pieske B, Redfield MM, Rouleau JL, van Veldhuisen DJ, Zannad F, Zile MR, Desai AS, Claggett B, Jhund PS, Boytsov SA, Comin-Colet J, Cleland J, Düngen HD, Goncalvesova E, Katova T, Kerr Saraiva JF, Lelonek M, Merkely B, Senni M, Shah SJ, Zhou J, Rizkala AR, Gong J, Shi VC, Lefkowitz MP; PARAGON-HF Investigators and Committees.

N Engl J Med. 2019 Sep 1. doi: 10.1056/NEJMoa1908655. [Epub ahead of print]

PMID:
31475794
5.

Coronary Plaque Features on CTA Can Identify Patients at Increased Risk of Cardiovascular Events.

Andreini D, Magnoni M, Conte E, Masson S, Mushtaq S, Berti S, Canestrari M, Casolo G, Gabrielli D, Latini R, Marraccini P, Moccetti T, Modena MG, Pontone G, Gorini M, Maggioni AP, Maseri A; CAPIRE Investigators.

JACC Cardiovasc Imaging. 2019 Aug 8. pii: S1936-878X(19)30611-4. doi: 10.1016/j.jcmg.2019.06.019. [Epub ahead of print]

PMID:
31422137
6.

Effects of Dipeptidyl Peptidase-4 Inhibitor Linagliptin on Left Ventricular Dysfunction in Patients with Type 2 Diabetes and Concentric Left Ventricular Geometry (the DYDA 2™ Trial). Rationale, Design, and Baseline Characteristics of the Study Population.

Giorda CB, Cioffi G, Lucci D, Nada E, Ognibeni F, Mancusi C, Latini R, Maggioni AP; DYDA 2 Investigators.

Cardiovasc Drugs Ther. 2019 Aug 15. doi: 10.1007/s10557-019-06898-6. [Epub ahead of print]

PMID:
31418140
7.

Stroke prevention by low-dose anticoagulation in patients with heart failure and sinus rhythm: is it worth the effort?

Maggioni AP, Andreotti F.

Eur Heart J. 2019 Aug 1. pii: ehz523. doi: 10.1093/eurheartj/ehz523. [Epub ahead of print] No abstract available.

PMID:
31369067
8.

Reproducibility of in-hospital worsening heart failure event adjudication in the RELAX-AHF-EU trial.

Hallén J, Maggioni AP, Lopez-De-Sa E, Turazza FM, Witte K, Erdmann E, Dahlström U, Ertl G, Nielsen OW, Sendon JL, Holbro T, Chen CW, Gimpelewicz C, Cowie MR.

Eur J Heart Fail. 2019 Jul 29. doi: 10.1002/ejhf.1574. [Epub ahead of print] No abstract available.

PMID:
31359535
9.

THE ESC ACCA EAPCI EORP Acute Coronary Syndrome ST elevation myocardial infarction (ACS STEMI) REGISTRY.

Zeymer U, Ludman P, Danchin N, Kala P, Maggioni AP, Weidinger F.

Eur Heart J Qual Care Clin Outcomes. 2019 Jul 30. pii: qcz042. doi: 10.1093/ehjqcco/qcz042. [Epub ahead of print]

PMID:
31359068
10.

Influence of risk factors in the ESC-EHRA EORP atrial fibrillation ablation long-term registry.

Trines SA, Stabile G, Arbelo E, Dagres N, Brugada J, Kautzner J, Pokushalov E, Maggioni AP, Laroche C, Anselmino M, Beinart R, Traykov V, Blomström-Lundqvist C; ESC-EHRA Atrial Fibrillation Ablation Long-Term Registry investigators.

Pacing Clin Electrophysiol. 2019 Jul 29. doi: 10.1111/pace.13763. [Epub ahead of print]

PMID:
31355938
11.

Omega-3 Fatty Acids and Heart Failure: Evidence and Still Open Questions.

Maggioni AP.

JACC Heart Fail. 2019 Aug;7(8):662-663. doi: 10.1016/j.jchf.2019.04.007. Epub 2019 Jul 10. No abstract available.

PMID:
31302045
12.

Health-Related Quality of Life in Heart Failure With Preserved Ejection Fraction: The PARAGON-HF Trial.

Chandra A, Vaduganathan M, Lewis EF, Claggett BL, Rizkala AR, Wang W, Lefkowitz MP, Shi VC, Anand IS, Ge J, Lam CSP, Maggioni AP, Martinez F, Packer M, Pfeffer MA, Pieske B, Redfield MM, Rouleau JL, Van Veldhuisen DJ, Zannad F, Zile MR, McMurray JJV, Solomon SD; PARAGON-HF Investigators.

JACC Heart Fail. 2019 Jul 10. pii: S2213-1779(19)30409-3. doi: 10.1016/j.jchf.2019.05.015. [Epub ahead of print]

PMID:
31302043
13.

Rivaroxaban With or Without Aspirin in Patients With Heart Failure and Chronic Coronary or Peripheral Artery Disease.

Branch KR, Probstfield JL, Eikelboom JW, Bosch J, Maggioni AP, Cheng RK, Bhatt DL, Avezum A, Fox KAA, Connolly SJ, Shestakovska O, Yusuf S.

Circulation. 2019 Aug 13;140(7):529-537. doi: 10.1161/CIRCULATIONAHA.119.039609. Epub 2019 Jun 5.

PMID:
31163978
14.

Safety of Proton Pump Inhibitors Based on a Large, Multi-Year, Randomized Trial of Patients Receiving Rivaroxaban or Aspirin.

Moayyedi P, Eikelboom JW, Bosch J, Connolly SJ, Dyal L, Shestakovska O, Leong D, Anand SS, Störk S, Branch KRH, Bhatt DL, Verhamme PB, O'Donnell M, Maggioni AP, Lonn EM, Piegas LS, Ertl G, Keltai M, Bruns NC, Muehlhofer E, Dagenais GR, Kim JH, Hori M, Steg PG, Hart RG, Diaz R, Alings M, Widimsky P, Avezum A, Probstfield J, Zhu J, Liang Y, Lopez-Jaramillo P, Kakkar AK, Parkhomenko AN, Ryden L, Pogosova N, Dans AL, Lanas F, Commerford PJ, Torp-Pedersen C, Guzik TJ, Vinereanu D, Tonkin AM, Lewis BS, Felix C, Yusoff K, Metsarinne KP, Fox KAA, Yusuf S; COMPASS Investigators.

Gastroenterology. 2019 Sep;157(3):682-691.e2. doi: 10.1053/j.gastro.2019.05.056. Epub 2019 May 29.

PMID:
31152740
15.

Sacubitril/valsartan eligibility and outcomes in the ESC-EORP-HFA Heart Failure Long-Term Registry: bridging between European Medicines Agency/Food and Drug Administration label, the PARADIGM-HF trial, ESC guidelines, and real world.

Kapelios CJ, Lainscak M, Savarese G, Laroche C, Seferovic P, Ruschitzka F, Coats A, Anker SD, Crespo-Leiro MG, Filippatos G, Piepoli MF, Rosano G, Zanolla L, Aguiar C, Murin J, Leszek P, McDonagh T, Maggioni AP, Lund LH; HF-LT Registry Investigators Group.

Eur J Heart Fail. 2019 May 27. doi: 10.1002/ejhf.1532. [Epub ahead of print]

PMID:
31132222
16.

Acute heart failure congestion and perfusion status - impact of the clinical classification on in-hospital and long-term outcomes; insights from the ESC-EORP-HFA Heart Failure Long-Term Registry.

Chioncel O, Mebazaa A, Maggioni AP, Harjola VP, Rosano G, Laroche C, Piepoli MF, Crespo-Leiro MG, Lainscak M, Ponikowski P, Filippatos G, Ruschitzka F, Seferovic P, Coats AJS, Lund LH; ESC-EORP HFA Heart Failure Long-Term Registry Investigators.

Eur J Heart Fail. 2019 May 24. doi: 10.1002/ejhf.1492. [Epub ahead of print]

PMID:
31127678
17.

Appropriate prescriptions mean better outcomes: how can we improve ourselves?

Maggioni AP.

Eur J Heart Fail. 2019 Jul;21(7):930-931. doi: 10.1002/ejhf.1476. Epub 2019 May 16. No abstract available.

PMID:
31099172
18.

[Facts and figures of clinical pathways in Italy: results from the PDTA Net project.]

Piccinni C, Calabria S, Ronconi G, Dondi L, Pedrini A, Esposito I, Marangolo M, Maggioni AP, Martini N.

Recenti Prog Med. 2019 Apr;110(4):188-194. doi: 10.1701/3154.31344. Italian.

PMID:
31066364
19.

Cardiovascular Effects of Pioglitazone or Sulfonylureas According to Pretreatment Risk: Moving Toward Personalized Care.

Vaccaro O, Lucisano G, Masulli M, Bonora E, Del Prato S, Rivellese AA, Giorda CB, Mocarelli P, Squatrito S, Maggioni AP, Riccardi G, Nicolucci A; TOSCA.IT Investigators.

J Clin Endocrinol Metab. 2019 Aug 1;104(8):3296-3302. doi: 10.1210/jc.2019-00361.

PMID:
31058962
20.

Pantoprazole to Prevent Gastroduodenal Events in Patients Receiving Rivaroxaban and/or Aspirin in a Randomized, Double-Blind, Placebo-Controlled Trial.

Moayyedi P, Eikelboom JW, Bosch J, Connolly SJ, Dyal L, Shestakovska O, Leong D, Anand SS, Störk S, Branch KRH, Bhatt DL, Verhamme PB, O'Donnell M, Maggioni AP, Lonn EM, Piegas LS, Ertl G, Keltai M, Cook Bruns N, Muehlhofer E, Dagenais GR, Kim JH, Hori M, Steg PG, Hart RG, Diaz R, Alings M, Widimsky P, Avezum A, Probstfield J, Zhu J, Liang Y, Lopez-Jaramillo P, Kakkar A, Parkhomenko AN, Ryden L, Pogosova N, Dans A, Lanas F, Commerford PJ, Torp-Pedersen C, Guzik T, Vinereanu D, Tonkin AM, Lewis BS, Felix C, Yusoff K, Metsarinne K, Fox KAA, Yusuf S; COMPASS Investigators.

Gastroenterology. 2019 Aug;157(2):403-412.e5. doi: 10.1053/j.gastro.2019.04.041. Epub 2019 May 2.

PMID:
31054846

Supplemental Content

Loading ...
Support Center